Steve2324

NovaDel Pharma: Won't Be Long Before Big Pharma Partners Come Calling

Do these stock analysts ever spend more than 5 minutes on DD?

No mention of filmstrip technology?

No mention of NVD's failed partnerships?

No discussion of why Nitromist, approved in 2006, never made it to the shelves?

These stock analysts are worse pumpers than the yahoos on, well, Yahoo.

Biotech: The Next Big Bubble?

I hate Mickey's patronizing, condescending tone. And his gushing over Aschoff is downright embarrassing. Get a room, Andrew.

There WAS a biotech bubble in December through the 1st week of January, but not for the reasons Mickey states. He probably got lucky on a few stocks, and of course he'll claim it was through shrewd analysis and the teachings of Professor Aschoff, but a chimpanzee could have picked penny biotechs for about 4 weeks there.

Aschoff is a PhD, not a medical doctor, and he's been bashing DNDN for 5 years. No matter what DNDN releases in a PR, Aschoff bashes it, ignoring facts and Data Analysis 101.

When Provenge is approved, I hope Andrew Mickey and "Dr." Aschoff both have DNDN shorted to the gills in an overseas account. Put your money where your mouths are, boys.